Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
ivano.mezzaroma@uniroma1.it
Ivano Mezzaroma
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
ivano.mezzaroma@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies
FRONTIERS IN IMMUNOLOGY
2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)
CARDIOVASCULAR DIABETOLOGY
2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
DIABETES RESEARCH AND CLINICAL PRACTICE
2020
Physical activity and HIV. Effects on fitness status, metabolism, inflammation and immune-activation
AIDS AND BEHAVIOR
2020
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2019
Copy-years viremia and risk of virological failure in long-term-treated HIV patients
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2019
Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
AIDS AND BEHAVIOR
2019
The effect of switching to Maraviroc + Darunavir/Ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis. Findings from a randomized study
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2019
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation
CURRENT HIV RESEARCH
2019
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
BMC INFECTIOUS DISEASES
2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
BMC INFECTIOUS DISEASES
2018
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
2018
TREATED HIV-1 PATIENTS WITH DIFFERENT LEVELS OF VIRAL SUPPRESSION: CHANGES IN MICRORNA EXPRESSION PROFILES
abstract book Congresso SIV-ISV
2018
HIV-1 DIVERSITY AND ANTIRETROVIRAL RESISTANCE MUTATIONS AMONG TREATMENT NAÏVE PATIENTS FROM 2005-2017: A SINGLE CENTER EXPERIENCE
Abstract book SIV congress 2018
2018
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
BMC INFECTIOUS DISEASES
2017
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors
AIDS
2017
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients
BRAIN AND BEHAVIOR
2017
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians
BMC INFECTIOUS DISEASES
2017
Long-term treatment with raltegravir is associated with lower triglycerides and platelets count in the older HIV+ population: Results from the Ral-Age study
CURRENT HIV RESEARCH
2017
« prima
< precedente
1
2
3
seguente ›
ultima »
Keywords
acute/early hiv infection
HIV
HCV
SARS- CoV-2
Primary immune deficiency and immune dysregulation disorder (PIDD)
Progetti di Ricerca
Correlazione tra steatosi non alcolica (NAFLD), attivazione piastrinica, stress ossidativo e traslocazione batterica in pazienti con infezione HIV
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma